Related Experiment Video
Updated: Jul 16, 2025

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
Stem cell-based therapies for heart failure management: a narrative review of current evidence and future
Gbolahan Olatunji1, Emmanuel Kokori1, Ismaila Yusuf2
1Department of Medicine and Surgery, University of Ilorin, Ilorin, Nigeria.
Insights
Stem cell therapies offer a promising new avenue for treating heart failure (HF), potentially improving cardiac function and quality of life. Rigorous safety assessments and personalized approaches are crucial for future advancements in this field.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Stem Cell Biology
Background:
- Heart failure (HF) affects millions globally, necessitating novel treatments beyond symptom management.
- Current therapies for HF primarily focus on alleviating symptoms rather than addressing root causes.
- The rising prevalence of HF demands innovative therapeutic strategies to restore cardiac function.
Purpose of the Study:
- To review the current status of stem cell-based therapies for heart failure management.
- To explore the mechanisms, clinical evidence, ethical considerations, and regulatory aspects of these therapies.
- To identify future directions for enhancing the efficacy and safety of stem cell treatments for HF.
Main Methods:
- Comprehensive literature review of stem cell-based therapies for heart failure.
- Analysis of clinical trial data, including both positive and negative outcomes.
- Examination of ethical considerations and regulatory hurdles in stem cell therapy development.
Main Results:
- Stem cell therapies demonstrate potential for improving cardiac function and patient quality of life in HF.
- Evidence suggests possible long-term benefits, but adverse events necessitate thorough safety evaluations.
- Optimizing stem cell types, delivery, and dosage are key to enhancing therapeutic outcomes.
Conclusions:
- Stem cell therapies represent a significant advancement in heart failure treatment, moving beyond conventional approaches.
- Further research is needed to refine safety protocols, personalize treatments, and address ethical/regulatory challenges.
- Expanding access and reducing costs are vital for the widespread adoption of these innovative therapies.
Abstract:
Heart failure (HF) is a prevalent and debilitating global cardiovascular condition affecting around 64 million individuals, placing significant strain on healthcare systems and diminishing patients' quality of life. The escalating prevalence of HF underscores the urgent need for innovative therapeutic approaches that target the root causes and aim to restore normal cardiac function. Stem cell-based therapies have emerged as promising candidates, representing a fundamental departure from conventional treatments focused primarily on symptom management. This review explores the evolving landscape of stem cell-based therapies for HF management. It delves into the mechanisms of action, clinical evidence from both positive and negative outcomes, ethical considerations, and regulatory challenges. Key findings include the potential for improved cardiac function, enhanced quality of life, and long-term benefits associated with stem cell therapies. However, adverse events and patient vulnerabilities necessitate stringent safety assessments. Future directions in stem cell-based HF therapies include enhancing efficacy and safety through optimized stem cell types, delivery techniques, dosing strategies, and long-term safety assessments. Personalized medicine, combining therapies, addressing ethical and regulatory challenges, and expanding access while reducing costs are crucial aspects of the evolving landscape.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Heart Failure VI: Adjunct Therapies
Stem Cell Culture
Heart Failure V: Medical Management
iPS Cell Differentiation
Cardiomyopathy V: Interprofessional Care

